State Street Corp Applied Therapeutics Inc. Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 2,066,336 shares of APLT stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,066,336

Previous 3,694,607 44.07%

Holding current value

$1.1 Million

Previous $31.4 Million 94.41%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$0.82 - $10.24 $1.34 Million - $16.7 Million	-1,628,271 Reduced 44.07%	2,066,336 $1.76 Million
Q3 2024 Nov 14, 2024	BUY	$4.35 - $8.5 $8.87 Million - $17.3 Million	2,038,724 Added 123.12%	3,694,607 $31.4 Million
Q2 2024 Aug 14, 2024	BUY	$4.04 - $6.37 $5.85 Million - $9.23 Million	1,449,214 Added 701.22%	1,655,883 $7.73 Million
Q1 2024 May 15, 2024	BUY	$2.25 - $7.4 $148,500 - $488,400	66,000 Added 46.92%	206,669 $1.41 Million
Q4 2023 Feb 14, 2024	BUY	$1.84 - $3.35 $6,256 - $11,390	3,400 Added 2.48%	140,669 $471,000
Q3 2023 Nov 14, 2023	BUY	$1.26 - $2.77 $93,919 - $206,473	74,539 Added 118.83%	137,269 $341,000
Q2 2023 Aug 14, 2023	SELL	$0.77 - $1.8 $24,397 - $57,033	-31,685 Reduced 33.56%	62,730 $80,000
Q2 2022 Aug 15, 2022	SELL	$0.76 - $2.64 $252,311 - $876,450	-331,989 Reduced 77.86%	94,415 $90,000
Q1 2022 May 16, 2022	BUY	$1.48 - $6.22 $125,434 - $527,163	84,753 Added 24.81%	426,404 $900,000
Q4 2021 Feb 14, 2022	BUY	$8.77 - $18.29 $242,929 - $506,633	27,700 Added 8.82%	341,651 $3.06 Million
Q3 2021 Nov 15, 2021	BUY	$13.54 - $22.06 $397,832 - $648,166	29,382 Added 10.33%	313,951 $5.21 Million
Q2 2021 Aug 16, 2021	BUY	$14.05 - $25.04 $618,958 - $1.1 Million	44,054 Added 18.32%	284,569 $5.91 Million
Q1 2021 May 17, 2021	BUY	$16.57 - $28.65 $110,687 - $191,382	6,680 Added 2.86%	240,515 $4.51 Million
Q4 2020 Feb 16, 2021	SELL	$15.44 - $24.23 $80,442 - $126,238	-5,210 Reduced 2.18%	233,835 $5.15 Million
Q3 2020 Nov 10, 2020	SELL	$19.43 - $35.36 $67,635 - $123,088	-3,481 Reduced 1.44%	239,045 $4.96 Million
Q2 2020 Aug 14, 2020	BUY	$29.41 - $51.23 $3.04 Million - $5.3 Million	103,482 Added 74.42%	242,526 $8.77 Million
Q1 2020 May 11, 2020	BUY	$19.54 - $55.47 $2.72 Million - $7.71 Million	139,044 New	139,044 $4.55 Million

Others Institutions Holding APLT

# of Institutions

130

Shares Held

112M

Call Options Held

1.1M

Put Options Held

800K

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $25.5M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Applied Therapeutics Inc. Transaction History